Canton Strategic Holdings, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
2.060
+0.130 (6.74%)
At close: Nov 6, 2026, 4:00 PM EST
2.080
+0.020 (0.97%)
After-hours: Nov 6, 2026, 7:59 PM EST
Canton Strategic Holdings Market Cap
Canton Strategic Holdings has a market cap or net worth of $164.14 million as of November 6, 2026. It is the 21,612th most valuable company in the world and the 3,687th biggest in the United States. Its market cap has increased by 378.76% in one year.
Market Cap
164.14M
Enterprise Value
126.90M
1-Year Change
378.76%
Global Rank
Country Rank
#3,687 United States
Category
ChartMarket Cap Chart
Since January 12, 2022, Canton Strategic Holdings's market cap has increased from $32.56M to $164.14M, an increase of 404.09%. That is a compound annual growth rate of 39.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 164.14M | 48.64% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -86.20% |
| Jan 12, 2022 | 32.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 178.44M |
| Upstream Bio | 176.91M |
| Entrada Therapeutics | 176.32M |
| PepGen | 171.07M |
| Invivyd | 165.95M |
| BridgeBio Oncology Therapeutics | 163.56M |
| Zentalis Pharmaceuticals | 162.84M |
| Oramed Pharmaceuticals | 160.57M |